Citation
(2011), "Comparative cardiovascular effects of thiazolidinediones", Clinical Governance: An International Journal, Vol. 16 No. 3. https://doi.org/10.1108/cgij.2011.24816caa.011
Publisher
:Emerald Group Publishing Limited
Copyright © 2011, Emerald Group Publishing Limited
Comparative cardiovascular effects of thiazolidinediones
Comparative cardiovascular effects of thiazolidinediones
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 16, Issue 3
Loke, Y.K., Kwok, C.S., Singh, S.Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studiesBMJ2011Vol. 342d1309
This review concluded that in patients with type 2 diabetes, rosiglitazone was associated with significantly higher odds of congestive heart failure, myocardial infarction, and death, than pioglitazone, in real-world settings. This was a generally well-conducted review. The authors acknowledged the methodological limitations of the evidence available and the conclusions are likely to be reliable.